XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 135 filers reported holding XENON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 10.04 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,305,833 | +5.0% | 243,145 | +18.3% | 0.00% | 0.0% |
| Q2 2023 | $7,913,137 | -9.0% | 205,536 | -15.4% | 0.00% | 0.0% |
| Q1 2023 | $8,696,290 | +150.2% | 242,981 | +175.7% | 0.00% | – |
| Q4 2022 | $3,475,125 | -39.2% | 88,134 | -44.4% | 0.00% | -100.0% |
| Q3 2022 | $5,720,000 | -81.2% | 158,452 | -84.1% | 0.00% | -75.0% |
| Q2 2022 | $30,362,000 | -31.0% | 998,072 | -30.7% | 0.00% | -33.3% |
| Q1 2022 | $44,026,000 | +61.6% | 1,440,171 | +65.1% | 0.01% | +100.0% |
| Q4 2021 | $27,243,000 | +4272.9% | 872,084 | +2040.8% | 0.00% | – |
| Q3 2021 | $623,000 | -36.4% | 40,736 | -22.6% | 0.00% | – |
| Q2 2021 | $979,000 | +1000.0% | 52,600 | +960.7% | 0.00% | – |
| Q1 2021 | $89,000 | +134.2% | 4,959 | +101.7% | 0.00% | – |
| Q4 2020 | $38,000 | +40.7% | 2,459 | 0.0% | 0.00% | – |
| Q3 2020 | $27,000 | -12.9% | 2,459 | -1.6% | 0.00% | – |
| Q2 2020 | $31,000 | -50.0% | 2,499 | -54.1% | 0.00% | – |
| Q1 2020 | $62,000 | +17.0% | 5,445 | +34.0% | 0.00% | – |
| Q4 2019 | $53,000 | -24.3% | 4,062 | -47.3% | 0.00% | – |
| Q3 2019 | $70,000 | +14.8% | 7,715 | +25.5% | 0.00% | – |
| Q2 2019 | $61,000 | +24.5% | 6,148 | +25.3% | 0.00% | – |
| Q1 2019 | $49,000 | -77.6% | 4,907 | -85.8% | 0.00% | – |
| Q4 2018 | $219,000 | +90.4% | 34,676 | +297.5% | 0.00% | – |
| Q3 2018 | $115,000 | +296.6% | 8,723 | +175.5% | 0.00% | – |
| Q2 2018 | $29,000 | +262.5% | 3,166 | +91.1% | 0.00% | – |
| Q1 2018 | $8,000 | -73.3% | 1,657 | -84.0% | 0.00% | – |
| Q4 2017 | $30,000 | -88.4% | 10,325 | -87.4% | 0.00% | – |
| Q2 2017 | $259,000 | +3137.5% | 82,242 | +3797.7% | 0.00% | – |
| Q1 2017 | $8,000 | -55.6% | 2,110 | -7.1% | 0.00% | – |
| Q4 2016 | $18,000 | -21.7% | 2,272 | -19.2% | 0.00% | – |
| Q3 2016 | $23,000 | +360.0% | 2,811 | +206.5% | 0.00% | – |
| Q2 2016 | $5,000 | -16.7% | 917 | 0.0% | 0.00% | – |
| Q1 2016 | $6,000 | -14.3% | 917 | 0.0% | 0.00% | – |
| Q4 2015 | $7,000 | -78.8% | 917 | -67.6% | 0.00% | – |
| Q2 2015 | $33,000 | +560.0% | 2,829 | +773.1% | 0.00% | – |
| Q1 2015 | $5,000 | – | 324 | +1308.7% | 0.00% | – |
| Q4 2014 | $0 | – | 23 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |